Document is current

Article History

Accepted: 20 December 2020

First Online: 26 February 2021

Declarations

:

: The planning and delivery of this project was funded by Janssen UK. All authors received honoraria for their time spent at the group meeting. The sponsor was not involved in the voting, discussion or handling of data.

: TR has received research/educational grants and/or speaker/consultation fees from AbbVie, BMS, Celgene, Ferring, Gilead, GSK, LabGenius, Janssen, Mylan, MSD, Novartis, Pfizer, Sandoz, Takeda and UCB. MG has received educational grants and/or speaker/consultation fees from AbbVie, Janssen, Novartis, LEO Pharma, Eli Lilly, Almirall, Celgene, Sanofi and Regenlab. PMI has received honoraria for acting in an advisory capacity for or speaking on behalf of AbbVie, Warner Chilcott, Ferring, Dr. Falk Pharma, Takeda, MSD, Janssen, Shire, Pfizer, Tillotts, Sandoz, Lilly, Celgene, Prometheus, Gilead, TopiVert, Genentech, Hospira, Samsung Bioepis and VH2; grants for research support from MSD, Takeda and Janssen. AK has no conflicts of interest that are directly relevant to the content of this article. EK has received speaker/consultation fees and/or educational support to attend conferences from AbbVie, Novartis, Janssen, Eli Lilly and GSK. PL has received honoraria and/or grants as an investigator, speaker and/or advisory board member for AbbVie, Actelion, Celgene, Janssen, Leo, Sanofi, UCB, Almirall and Novartis. ACF has received educational support to attend conferences from or acted as a consultant or speaker for AbbVie, Almirall, Celgene, Eli Lilly, LEO Pharma, Novartis, Pfizer, Janssen and UCB.

: Not applicable.

: Not applicable.

: All consensus statements and voting results are included in the manuscript.

: Not applicable.

: All authors participated in the consensus statement development and in the drafting, critical revision and approval of the final version of this manuscript.